Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 43 | Taylor Tate DeborahDirector |  HSTMHEALTHSTREAM INCOpen-market sale | SELL | $106K 3,281 sh | Nov 6, 2026 |
| 43 | Sabag MarkSee "Remarks" |  TEVATEVA PHARMACEUTICAL INDUSTRIES LTDOpen-market sale | SELL | $1.93M 46.0K sh | Nov 6, 2026 traded Nov 5, 2026 |
| 43 | O'Hara Kevin PExecutive Vice President | HSTMHEALTHSTREAM INC Open-market sale | SELL | $124K 4,000 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 43 | Collier Michael ManningExecutive Vice President | HSTMHEALTHSTREAM INC Open-market sale | SELL | $101K 3,300 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 42 | Pitofsky JasonSVP Controller |  REGNREGENERON PHARMACEUTICALS, INC.Open-market sale | SELL | $1.14M 1,215 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 41 | Stillwell KennethCOO, CFO |  PEGAPEGASYSTEMS INCOpen-market sale | SELL | $578K 16.3K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 41 | Koren OferCFO |  GLBEGlobal-E Online Ltd.Open-market sale | SELL | $550K 12.5K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 41 | Baker Bros. Advisors LpDirector, 10% Owner |  KODKodiak Sciences Inc.Open-market purchase | BUY | $14.97M 151.9K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 41 | Kinder Richard DDirector, Executive Chairman, 10% Owner |  KMIKINDER MORGAN, INC.Open-market purchase | BUY | $14.99M 500.0K sh | Nov 6, 2026 traded Nov 6, 2026 |
| 41 | Crowl BenChief Lending Officer, EVP |  FSBWFS Bancorp, Inc.Open-market sale | SELL | $236K 5,399 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 41 | Hoffman Michael BDirector |  ANVSAnnovis Bio, Inc.Open-market purchase | BUY | — 5.00M sh | Nov 6, 2026 traded Nov 6, 2026 |
| 40 |  Wilhelmsen Arne AlexanderDirector |  RCLROYAL CARIBBEAN CRUISES LTDOpen-market sale | SELL | $4.96M 15.4K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 40 | Schlosser Michael JEVP and Chief Clinical Officer |  HCAHCA Healthcare, Inc.Open-market sale | SELL | $594K 1,200 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 40 | Wilhelmsen Arne AlexanderDirector | RCLROYAL CARIBBEAN CRUISES LTD Open-market sale | SELL | $2.11M 6,577 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 40 | Klein NirDirector, Chief Executive Officer |  SYNXSilynxcom Ltd.Open-market purchase | BUY | $9,807 10.0K sh | Nov 6, 2026 traded Nov 3, 2026 |
| 40 | Bergwerk DovInterim Cheif Legal Officer | TEVATEVA PHARMACEUTICAL INDUSTRIES LTD Open-market sale | SELL | $365K 8,755 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 40 | Capuano AnthonyDirector, President & CEO |  MARMARRIOTT INTERNATIONAL INC /MD/Open-market sale | SELL | $1.13M 2,710 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 40 | Wilhelmsen Arne AlexanderDirector | RCLROYAL CARIBBEAN CRUISES LTD Open-market sale | SELL | $2.97M 8,934 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 40 | Wilhelmsen Arne AlexanderDirector | RCLROYAL CARIBBEAN CRUISES LTD Open-market sale | SELL | $8.30M 25.7K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 40 | Treff Douglas JDirector |  CROXCrocs, Inc.Open-market sale | SELL | $1.71M 10.7K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 40 | Rey David ADirector |  FICOFAIR ISAAC CORPOpen-market purchase | BUY | $7,367 8 sh | Nov 6, 2026 traded Sep 22, 2026 |
| 40 | Capuano AnthonyDirector, President & CEO | MARMARRIOTT INTERNATIONAL INC /MD/ Open-market sale | SELL | $1.41M 3,364 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 40 | Capuano AnthonyDirector, President & CEO | MARMARRIOTT INTERNATIONAL INC /MD/ Open-market sale | SELL | $1.53M 3,612 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 40 | Capuano AnthonyDirector, President & CEO | MARMARRIOTT INTERNATIONAL INC /MD/ Open-market sale | SELL | $2.38M 5,605 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 40 | Baker James CDirector, President |  KYNKayne Anderson Energy Infrastructure Fund, Inc.Open-market purchase | BUY | $331K 25.0K sh | Nov 6, 2026 traded Nov 5, 2026 |
| 40 | Wilhelmsen Arne AlexanderDirector | RCLROYAL CARIBBEAN CRUISES LTD Open-market sale | SELL | $3.87M 11.9K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 40 | Wilhelmsen Arne AlexanderDirector | RCLROYAL CARIBBEAN CRUISES LTD Open-market sale | SELL | $1.29M 3,978 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 40 | Wilhelmsen Arne AlexanderDirector | RCLROYAL CARIBBEAN CRUISES LTD Open-market sale | SELL | $1.92M 5,870 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 40 | Wilhelmsen Arne AlexanderDirector | RCLROYAL CARIBBEAN CRUISES LTD Open-market sale | SELL | $3.87M 11.7K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 40 | Wilhelmsen Arne AlexanderDirector | RCLROYAL CARIBBEAN CRUISES LTD Open-market sale | SELL | $6.05M 18.3K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 40 | Wilhelmsen Arne AlexanderDirector | RCLROYAL CARIBBEAN CRUISES LTD Open-market sale | SELL | $8.86M 26.5K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 40 | Elsener William ThomasEVP, Reservoir Engineering |  MTDRMatador Resources CoOpen-market purchase | BUY | $46K 900 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 40 | Fletcher Jeremy AdamEVP & CFO |  ORLYO REILLY AUTOMOTIVE INCOpen-market sale | SELL | $988K 10.6K sh | Nov 6, 2026 traded Nov 5, 2026 |
| 40 | Wilhelmsen Arne AlexanderDirector | RCLROYAL CARIBBEAN CRUISES LTD Open-market sale | SELL | $3.58M 10.9K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 39 | Pitofsky JasonSVP Controller | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $541K 575 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 39 | White Matthew JChief Financial Officer |  LINLINDE PLCOpen-market sale | SELL | $8.22M 15.7K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 39 | Hunn Laurence NeilDirector, President and CEO |  ROPROPER TECHNOLOGIES INCOpen-market sale | SELL | $2.16M 4,366 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 39 | Hunn Laurence NeilDirector, President and CEO | ROPROPER TECHNOLOGIES INC Open-market sale | SELL | $4.77M 9,690 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 39 | Pitofsky JasonSVP Controller | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale | SELL | $499K 529 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 39 | Jordan Rhonda LDirector |  ESABESAB CorpOpen-market sale | SELL | $294K 3,733 sh | Nov 6, 2026 traded Nov 5, 2026 |
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
BCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K